Frequent injections in the eye can cause infection, inflammation, and glaucoma. Akari is developing PAS-nomacopan with potential for 4 or fewer doses a year for …
Stories
Frequent IVI Burdens
Patients experience significant burdens (fear, discomfort, disruptions to their lives) with geographic atrophy (GA) treatments that are dosed monthly or every …
GA and Loss of Central Vision
Geographic atrophy (GA) is sight threatening. It causes loss of central vision, development of scotomas (blind spots), reduced reading speed and night vision …
Watch the KOL Event Replay
Check out the playback of Akari’s virtual KOL event, PAS Nomacopan Potential in Geographic Atrophy (GA), featuring Elias Reichel, M.D., Tufts University School …
Join Us for a Virtual KOL Event
Join us for a virtual KOL event with Akari Therapeutics, featuring Elias Reichel, MD (Tufts University School of Medicine) who will discuss …
